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Abstract
Objective
Patients with Hirschsprung disease (HSCR) can experience obstructive symptoms despite adequate
resection. We sought to determine if submucosal nerve thickness or length of ganglionated bowel in the
resected specimen correlated with functional outcomes.

Methods
A retrospective study of patients who underwent surgery between 2015-2019 was performed. The resected
specimen was scanned to measure areas of the thickest submucosal nerves and the length of the
ganglionated segment. Functional outcomes were collected via chart review.

Results
Thirty patients were included. The median age at pull-through was 4.5 months (interquartile range {IQR} 0.5
- 6.7 months); 70% were male, and 57% had a Swenson pull-through. The median size of the thickest nerves
was 28 micrometers (IQR 24, 32). Three specimens had a nerve thickness of >40 micrometers. The median
length of the resected ganglionated segment was 4.4 cm (IQR 2.2, 7.2).
Out of the total, 53% of patients experienced post-operative enterocolitis; 13% required further surgery. At a
median of 25.3 months (IQR 17.6, 42.2 months) from pull-through, 33% did not require any bowel regimen
therapy. Utilizing logistic regression, neither submucosal nerve thickness nor length of the resected
ganglionic segment correlated with outcomes.

Conclusion
While continued bowel management therapy was common, no correlation was found between histologic
findings and functional outcomes.

Categories: Pathology, Pediatric Surgery
Keywords: nerve thickness, hirschsprung-associated enterocolitis, clinical pathology, hirschsprung disease, neonatal
surgery pediatric gi surgery

Introduction
Hirschsprung disease (HSCR) is a congenital aganglionosis of the rectum and colon that extends for a
variable distance proximally from the internal anal sphincter (IAS). It is associated with the absence of
ganglion cells in the submucosal and myenteric plexus, the absence of mucosal calretinin staining, and an
increase in acetylcholinesterase nerve fiber activity [1-4]. The high levels of excitatory neurotransmitters,
such as acetylcholine, lead to a spastic contraction of the diseased bowel, causing a functional obstruction
[5]. To fully relieve the obstruction, all aganglionic and neurally-abnormal bowel should be resected, pulling
through the normally ganglionated colon to just above the dentate line.
The transition zone (TZ) is a segment of the bowel between which ganglion cells first appear and where
nerve cells of normal size and diameter occur [2]. Ganglion cells are present in this area, but the
neuroanatomy remains abnormal, leading to poor function if used as part of the pull-through procedure.
Histological features of the TZ include subcircumferential aganglionosis, myenteric hypoganglionosis, and
abnormal extrinsic hypertrophic innervation [6-8]. Criteria for hypertrophic extrinsic nerves include 2+
nerves greater than 40μm in the histological specimen [7]. The subcircumferential aganglionosis is thought
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to occur for only 3cm proximal to the aganglionic segment leading to recommendations of resecting 5cm
beyond the most distal ganglionic biopsy site when performing a pull-through procedure [7-9]. However, the
length of the TZ, including the area of partial circumferential aganglionosis, can be variable based on the
length of the aganglionic bowel and has been documented to be as high as 30cm in those with long-segment
disease [2, 9-11].
It is well documented that patients who have TZ histopathology as part of the pulled-through bowel or have
an aganglionic pull-through, have a higher risk of postoperative complications, including constipation,
impaction, and enterocolitis [12,13]. Conversely, it is also seen that, despite undergoing complete resection
of the aganglionic and TZ colon, patients still suffer from severe constipation or episodes of enterocolitis.
Recent research has identified that the number of ganglion cells increases from the distal portion of the TZ
to the more proximal portion, but this pattern is not uniform [2]. Likewise, the cholinergic innervation
pattern is much less definitive in the more proximal portion compared to the distal TZ, creating difficulties
in precisely defining the proximal boundary of the TZ [1,6]. As it is known that complete resection of the TZ
leads to improved post-operative outcomes, such as a decreased risk of developing obstructive symptoms or
Hirschsprung-associated enterocolitis (HAEC), the question remains: how much normally ganglionated
bowel should be resected at the time of the pull-through procedure? We aim to answer this question by
determining if submucosal nerve thickness or length of ganglionated bowel in the resected specimen of
patients who underwent pull-through for Hirschsprung disease correlated with post-operative functional
outcomes, including the development of HAEC, need for redo surgical procedures, need for a bowel
management regimen, and the ability to achieve voluntary and/or social continence. This article was
previously presented as a meeting abstract at the 2021 EUPSA Annual Congress on September 3, 2021.

Materials And Methods
After institutional review board approval with waiver of informed consent due to the nature of the study, a
retrospective review of patients who underwent pull-through (PT) for HSCR at our institution between 20152019 was performed. Patients who had their initial pull-through performed at our institution and had
pathology specimens of the resected colonic segment available were included. The review occurred between
2020-2021 and consisted of a re-analysis of the resected specimen obtained at the time of the original PT. A
pediatric pathologist scanned the resected specimens to measure the length of the ganglionated segment
and the average thickness of the submucosal nerves at the proximal margin. The length of the ganglionated
segment was measured from the proximal margin to the end of the transitional zone, where normalappearing ganglion cells and nerves were identified. Nerve thickness was evaluated at cross-sections of the
proximal margin, submitted separately or as part of the PT segment, and was measured with Infinity
Analyze camera software (Lumenera, Ontario, Canada) attached to a microscope. The complete crosssection of the proximal margin was assessed, and the dimensions of the thickest nerves were measured. A
line segment was drawn across the widest diameter or width of the nerve, and the line length was measured
in micrometers. Average dimensions were calculated when more than one nerve is found. Demographic data,
intra-operative characteristics, and post-operative outcomes were collected via chart review. Post-operative
outcomes included the development of Hirschsprung-associated enterocolitis (HAEC), the need for bowel
regimen medications at any point after PT, redo surgical interventions, current bowel therapy regimen at last
follow-up, and occurrence of any soiling accidents.
All data were analyzed using STATA® (StataCorp, College Station, TX). Categorical data are expressed as
percentages and continuous data are expressed as medians with inter-quartile ranges (IQR). Logistic
regression was performed to identify if the size of the submucosal nerves or the length of the ganglionated
bowel in the resected specimen correlated with the development of enterocolitis, need for further surgery, or
obtaining continence of stool. A p-value of < 0.05 was considered statistically significant.

Results
Thirty patients were included in the analysis. The median age at pull-through was 4.5 months (IQR 0.5 - 6.7
months); 70% were male, and 73% were Caucasian. Seventeen patients (57%) had a Swenson pull-through,
while 13 (43%) underwent a Soave procedure; none of the patients had a Duhamel pull-through. The
transition zone was located in the rectosigmoid in 18 patients (Table 1). On pathological examination, the
median size of the thickest nerves was 28 micrometers (IQR 24, 32). Three specimens had an average nerve
thickness of >40 micrometers. The median length of the resected ganglionated segment was 4.4 cm (IQR 2.2,
7.2).
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Post Pull-through Patients (n=30)
Gender
-Male

21 (70%)

-Female

9 (30%)

Race/ Ethnicity
-Caucasian

22 (73%)

-African American

5 (17%)

-Hispanic

1 (0.6%)

-Asian

1 (0.6%)

-Other

1 (0.6%)

-Multi-racial

0 (0%)

Median Age at Pull-Through

4.5 months (0.5, 6.7)

Type of Pull-Through Procedure
-Swenson

17 (57%)

-Soave

13 (43%)

Transition Zone
-Rectosigmoid

18 (60%)

-Descending Colon

7 (23%)

-Transverse Colon

2 (7%)

-Ascending Colon/ TCA

3 (10%)

Duration of Follow-Up

25.3 months (17.6, 42.2)

TABLE 1: Demographics of the patients included in our analysis
(IQR = inter-quartile range)

Sixteen patients (53%) experienced post-operative HAEC, which was defined as admission to the hospital
with the performance of rectal irrigations and intravenous antibiotic administration for obstructive
symptomatology with or without lethargy, fevers, or poor oral intake; 5 (17%) required further surgery. One
underwent antegrade enema access, while four had a diverting ostomy with/without a redo pull-through
procedure. Three of the four patients who required a redo operation had developed HAEC after their initial
pull-through procedure. The need for a bowel management plan was evident, as 11 patients (37%) required
laxatives, and 14 (47%) performed rectal irrigation at home at some time point following pull-through. In
line with our recent practice change of performing botulinum toxin (BT) injections to the internal anal
sphincter to relieve obstructive symptoms, all but three patients had BT injections performed during their
long-term post-operative follow-up [14]. A comparison of outcome measures can be found in Figure 1. At a
median follow-up of 25.3 months (IQR 17.6, 42.2 months) from primary pull-through, 10 patients (33%) were
not requiring any therapy, 30% still utilized laxatives, and 33% still required intermittent irrigations. Of the
11 patients who were >4 years of age at the latest follow-up, eight (73%) were toilet-trained, and one (3%)
was clean of stool with the help of antegrade flushes; the success of toilet training was unknown in two (7%)
patients.
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FIGURE 1: Outcome measures in patients who underwent Swenson or
Soave pull-through for Hirschsprung disease
PRN = as needed

Logistic regression was utilized to assess the role that the submucosal nerve thickness and length of
ganglionated segment resected played in these postoperative outcomes. Neither submucosal nerve thickness
nor length of the resected ganglionic segment correlated with enterocolitis episodes, need for further
surgery, or obtaining stool continence (Table 2).
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Variable

Odds Ratio

95% Confidence Interval

P-value

Gender

3.0

0.48 – 18.74

0.24

Race

1.0

0.36 – 2.78

0.99

Transition Zone

0.42

0.16 – 1.12

0.08

Average Nerve Thickness

0.90

0.78 – 1.05

0.19

Length of Ganglionated Segment

0.78

0.55 – 1.10

0.09

Gender

1.0

-

-

Race

0.81

0.13 – 5.02

0.82

Transition Zone

0.97

0.30 – 3.14

0.96

Average Nerve Thickness

1.02

0.84 – 1.24

0.84

Length of Ganglionated Segment

0.98

0.87 – 1.10

0.78

Gender

0.61

0.94 – 3.97

0.61

Race

0.83

0.37 – 1.83

0.64

Transition Zone

1.22

0.45 – 3.29

0.70

Average Nerve Thickness

1.01

0.89 – 1.15

0.82

Length of Ganglionated Segment

1.01

0.93 – 1.09

0.79

Post-operative Enterocolitis

Need for Redo Pull-Through

Successful Social Continence

TABLE 2: Logistic Regression analysis looking at post-operative outcomes
Logistic regression was performed looking at three post-operative outcomes: incidence of post-operative Hirschsprung-associated enterocolitis, need for
redo pull-through, and success in obtaining social continence. The transition zone indicates the area of the colon where the transition zone was located.

Discussion
In our review of resected specimens of HSCR, we did not find any correlation between the length of the
resected ganglionated segment or the size of nerve fibers and postoperative complications, including HAEC,
need for redo surgery, or fecal continence. Our study produced similar results to a 2008 study that examined
the length of ganglionic and aganglionic bowel with resected colonic specimens in patients with HSCR [15].
In this study, no difference was found in enterocolitis rates among patients who had either >5cm or <5cm of
ganglionated bowel resected. There also was no difference in the mean thickness of submucosal nerves
between the two groups [15].
In a study performed by Saad et al, the histopathology of 35 patients was examined [4]. Patients were
grouped into those who had <3 episodes and those who had ≥3 episodes of HAEC episodes per year. Those
who had frequent attacks had significantly more common disarray of nerve bundles and a thicker nerve
bundle diameter at the proximal margin of the resected segment [4]. Increased nerve bundle thickness,
unmyelinated nerve bundles, and features of acute inflammation at the proximal margin were also
associated with poor outcomes. It is thought that these unmyelinated nerve bundles may play a role in
decreased colonic motility, potentially leading to constipation and obstructive symptoms [4]. This indicates
that the transition zone can be problematic to define; even in our study, three patients were found to have
some hypertrophic nerves at the resected margin. However, extra vigilance should be taken in caring for
these patients as it is unclear whether this leads to a higher incidence of postoperative complications. In our
study, all three patients with a nerve thickness >40µm required Botulinum toxin injection into the internal
anal sphincter, and one patient required a redo pull-through. Finally, in a retrospective review published in
2020, the length of the TZ was compared to the need for revisional surgery in 48 patients [16]. No difference
was found among patients who had a transition zone >5cm or ≤5cm when focusing on postoperative
complications or the need for revisional surgery [16]. While our study did not look specifically at the length
of the TZ, we found no difference in the length of the ganglionated segment proximal to the TZ and the
development of postoperative complications.
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It is well known that patients with a transition zone pull-through (TZPT) have a higher risk of
complications, such as HAEC, as the TZ can result in obstructive symptomatology [2,12]. In a systematic
review of patients who underwent a redo PT, 35% had abnormal findings on rectal biopsy, including 49/193
who had a TZPT; these patients most commonly presented with constipation and recurrent HAEC [17].
Similar findings were seen in another study, where they looked at 93 patients who required revisional
operations [13]. Twenty-five patients had residual aganglionosis or TZPT, and the prominent symptoms of
all patients were enterocolitis (56%) and constipation (44%). Thus, all patients who present with recurrent
obstructive symptoms should undergo a repeat rectal biopsy to confirm the presence of ganglion cells at the
level of anastomosis.
However, even patients who undergo an appropriate PT may still develop obstructive symptoms and HAEC,
and we are unable to predict which patients will develop these complications accurately. In a multicenter
retrospective review of nearly 300 patients by the Pediatric Colorectal and Pelvic Learning Consortium
(PCPLC), patients with a rectosigmoid transition zone had a lower association with postoperative HAEC
compared to a more proximal transition zone [18]. Other potentially important variables, such as insurance
status and incidence of preoperative HAEC were not found to be associated with postoperative HAEC on
multivariate analysis; the authors concluded that further multi-institutional studies were needed to identify
other potential risk factors [18]. In our study, we were unable to find any correlation in the length of the
resected ganglionic segment or in the size of the nerve fibers with postoperative functional outcomes;
however, we presume that there may be other histological factors that we have not examined could be
important risk factors.
Studies that have attempted to predict which patients will develop such symptoms have focused on the
histopathology of the resected colonic specimens. In one retrospective review that assessed the pattern of
cholinergic innervation and the number of ganglion cells in resected specimens, no definitive pattern could
be found between the amount of cholinergic innervation and ganglion cells [1]. Another observational study
evaluated the extent of the TZ in patients with HSCR; no relationship was found between the pattern of
distribution of nerve trunk hypertrophy and the distribution of hypoplastic ganglia [2]. Altered expression of
neurotransmitters also has been seen in the bowel of patients with HSCR [5]. In a study by Coyle et al.,
neuronal nitric oxide synthase was found to be higher in the ganglionated bowel of patients with HSCR and
reduced in the aganglionic segment compared to the bowel of patients without HSCR, while choline
acetyltransferase was higher in aganglionic bowel and lower in ganglionated bowel compared to controls [5].
The inverse relationship between nitric oxide synthase and choline acetyltransferase expression was
identified as a gradient traveling from the aganglionic bowel to the ganglionated bowel within the resected
specimens. The overexpression of choline acetyltransferase leads to the spastic contraction of the
aganglionic segment, while the neuronal nitric oxide synthase is believed to be responsible for the
hypomotile megacolon that may contribute to persistent symptoms in patients after pull-through [5]. Future
research in this area should focus on how different expression levels of these neurotransmitters play a role
in postoperative outcomes, such as HAEC, severe constipation, and the need for revisional surgery.
Patients with HSCR who require a bowel management program have different considerations compared to
those who have an anorectal malformation. Factors related to soiling and incontinence in the HSCR
population include both the motility of the colon (hypermotile vs hypomotile) as well as the post-surgical
anatomy, specifically if there has been damage to the sphincters and if the patient has sensation in the anal
canal [19]. It is believed that delaying the definitive pull-through until the patient is 3-4 months of age will
allow for better identification of perineal anatomy and avoidance of sphincter damage; however, a
retrospective review of 82 patients with HSCR within the PCPLC found no difference in short vs longsegment disease, preoperative or postoperative HAEC episodes, or in need for bowel management between
those who underwent pull-through in the neonatal period compared to those who underwent pull-through
in a delayed fashion [20]. The 48.5% rate of enterocolitis in the delayed group is similar to our findings,
where 57% experienced HAEC after undergoing a pull-through procedure at a median of 4.5 months of age.
Limitations of this study include its retrospective design and identifying variables that may be important in
predicting postoperative complications was limited by available documentation in the electronic medical
record. Due to the retrospective nature of this review, objective measures of functional outcomes could not
be calculated as aspects of previously validated scoring systems were not routinely documented in the
patient's charts during follow-up. Therefore, we used continence as a surrogate for functional outcomes as
the ultimate goal of all children with Hirschsprung disease is to remain either voluntarily or socially
continent. Previous studies have shown that a criterion of >40 μm for hypertrophic nerves may not be fully
accurate after the patient reaches one year of age [9,21]. We also did not look at expression levels of
neurotransmitters within the proximal portion of the specimen; this may be an area of future research to
determine if differences in expression correlate with an increased risk of postoperative obstructive
symptoms.

Conclusions
Patients with Hirschsprung disease can experience obstructive symptoms despite adequate resection. These
symptoms can lead to the development of enterocolitis, affect the patient’s ability to achieve fecal
continence, and may result in further procedures in order to allow for better stooling patterns. What is
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unclear is whether the length of the ganglionated bowel in the resected specimen or the thickness of the
submucosal nerves correlates with functional outcomes, specifically the presence of obstructive
symptomatology and the ability to achieve continence.
In our retrospective review, no correlation was found between histologic findings (submucosal nerve
thickness or length of ganglionated bowel in the resected specimen) and postoperative functional outcomes
following pull-through. The need for continued bowel management therapy was common; however, all
patients greater than age four years in whom toilet training status was known were socially continent.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Children's Mercy
Hospital Kansas City Institutional Review Board issued approval #16070512. The protocol was accepted and
approved to begin research in July 2019. Basic Study Information: 1. * Title of study-The Relationship of
Eosinophilia to Treatment and Outcomes of Hirschsprung’s Disease; 2. * Short title: HD and Eos; 3. * Brief
description: This will be a single center retrospective chart review and prospective observational study of
patients diagnosed with Hirschsprung’s disease. Long term follow-up will include five years from the date
the study begins to be able to capture the outcomes of the youngest patients. We will compare the overall
outcomes, interventions, complications and any differences in patients that were diagnosed with
Hirschsprung’s disease who were and were not found to have the presence of eosinophils on any pathologic
specimen; 4. * Principal investigator: Rebecca Rentea; 5. * Does the investigator have a financial interest
related to this research? No; 6. * Will an external IRB act as the IRB of record in the study? No; 7. * What
kind of study is this? Single-site study. Animal subjects: All authors have confirmed that this study did not
involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure
form, all authors declare the following: Payment/services info: All authors have declared that no financial
support was received from any organization for the submitted work. Financial relationships: All authors
have declared that they have no financial relationships at present or within the previous three years with
any organizations that might have an interest in the submitted work. Other relationships: All authors have
declared that there are no other relationships or activities that could appear to have influenced the
submitted work.

References
1.

2.
3.

4.

5.
6.
7.
8.
9.
10.
11.
12.

13.

14.

15.

Braczynski AK, Gfroerer S, Beschorner R, Harter PN, Baumgarten P, Rolle U, Mittelbronn M: Cholinergic
innervation and ganglion cell distribution in Hirschsprung's disease. BMC Pediatr. 2020, 20:399.
10.1186/s12887-020-02299-z
Coyle D, O'Donnell AM, Tomuschat C, Gillick J, Puri P: The extent of the transition zone in Hirschsprung
Disease. J Pediatr Surg. 2019, 54:2318-24. 10.1016/j.jpedsurg.2019.04.017
Najjar S, Ahn S, Umrau K, Erdem Arslan M, Jennings TA, Whyte C, Lee H: Increasing trend of calretininpositive mucosal innervation from aganglionic zone toward transition zone in Hirschsprung's Disease. Eur J
Pediatr Surg. 2022, 32:191-7. 10.1055/s-0041-1722859
Saad SA, Elseed MM, AbouZeid AA, Ibrahim EA, Radwan AB, Hay SA, El-Behery MM: Histopathological
perspective of the pulled-through colon in Hirschsprung disease: impact on clinical outcome. J Pediatr Surg.
2020, 55:1829-33. 10.1016/j.jpedsurg.2020.01.007
Coyle D, O'Donnell AM, Gillick J, Puri P: Altered neurotransmitter expression profile in the ganglionic
bowel in Hirschsprung's disease. J Pediatr Surg. 2016, 51:762-9. 10.1016/j.jpedsurg.2016.02.018
Kapur RP, Kennedy AJ: Transitional zone pull through: surgical pathology considerations . Semin Pediatr
Surg. 2012, 21:291-301. 10.1053/j.sempedsurg.2012.07.003
Kapur RP: Submucosal nerve diameter of greater than 40 µm is not a valid diagnostic index of transition
zone pull-through. J Pediatr Surg. 2016, 51:1585-91. 10.1016/j.jpedsurg.2016.06.007
Veras LV, Arnold M, Avansino JR, et al.: Guidelines for synoptic reporting of surgery and pathology in
Hirschsprung disease. J Pediatr Surg. 2019, 54:2017-23. 10.1016/j.jpedsurg.2019.03.010
Kapur RP, Kennedy AJ: Histopathologic delineation of the transition zone in short-segment Hirschsprung
disease. Pediatr Dev Pathol. 2013, 16:252-66. 10.2350/12-12-1282-OA.1
Ghosh DN, Liu Y, Cass DT, Soundappan SS: Transition zone pull-through in Hirschsprung's disease: a
tertiary hospital experience. ANZ J Surg. 2017, 87:780-3. 10.1111/ans.13745
Smith C, Ambartsumyan L, Kapur RP: Surgery, surgical pathology, and postoperative management of
patients with Hirschsprung Disease. Pediatr Dev Pathol. 2020, 23:23-39. 10.1177/1093526619889436
Coe A, Collins MH, Lawal T, Louden E, Levitt MA, Peña A: Reoperation for Hirschsprung disease: pathology
of the resected problematic distal pull-through. Pediatr Dev Pathol. 2012, 15:30-8. 10.2350/11-02-0977OA.1
Lawal TA, Chatoorgoon K, Collins MH, Coe A, Peña A, Levitt MA: Redo pull-through in Hirschsprung's
disease for obstructive symptoms due to residual aganglionosis and transition zone bowel. J Pediatr Surg.
2011, 46:342-7. 10.1016/j.jpedsurg.2010.11.014
Svetanoff WJ, Lopez J, Aguayo P, Hendrickson RJ, Oyetunji TA, Rentea RM: The impact of botulinum
injection for hospitalized children with Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2021,
37:1467-72. 10.1007/s00383-021-04966-3
Haricharan RN, Seo JM, Kelly DR, et al.: Older age at diagnosis of Hirschsprung disease decreases risk of
postoperative enterocolitis, but resection of additional ganglionated bowel does not. J Pediatr Surg. 2008,
43:1115-23. 10.1016/j.jpedsurg.2008.02.039

2022 Svetanoff et al. Cureus 14(10): e30809. DOI 10.7759/cureus.30809

7 of 8

16.
17.
18.

19.

20.
21.

Thakkar HS, Blackburn S, Curry J, De Coppi P, Giuliani S, Sebire N, Cross K: Variability of the transition
zone length in Hirschsprung disease. J Pediatr Surg. 2020, 55:63-6. 10.1016/j.jpedsurg.2019.09.056
Friedmacher F, Puri P: Residual aganglionosis after pull-through operation for Hirschsprung's disease: a
systematic review and meta-analysis. Pediatr Surg Int. 2011, 27:1053-7. 10.1007/s00383-011-2958-5
Kapur RP, Arnold MA, Conces MR, et al.: Remodeling of rectal innervation after pullthrough surgery for
Hirschsprung disease: relevance to criteria for the determination of retained transition zone. Pediatr Dev
Pathol. 2019, 22:292-303. 10.1177/1093526618817658
Taylor MA, Bucher BT, Reeder RW, et al.: Comparison of Hirschsprung disease characteristics between those
with a history of postoperative enterocolitis and those without: results from the Pediatric Colorectal and
Pelvic Learning Consortium. Eur J Pediatr Surg. 2021, 31:207-13. 10.1055/s-0040-1716876
Levitt MA, Dickie B, Peña A: The Hirschsprungs patient who is soiling after what was considered a
"successful" pull-through. Semin Pediatr Surg. 2012, 21:344-53. 10.1053/j.sempedsurg.2012.07.009
Kastenberg ZJ, Taylor MA, Durham MM, et al.: Perioperative and long-term functional outcomes of neonatal
versus delayed primary endorectal pull-through for children with Hirschsprung disease: A pediatric
colorectal and pelvic learning consortium study. J Pediatr Surg. 2021, 56:1465-9.
10.1016/j.jpedsurg.2021.04.024

2022 Svetanoff et al. Cureus 14(10): e30809. DOI 10.7759/cureus.30809

8 of 8

